骨质疏松症和正常血性原发性甲状腺功能障碍症 (保守或手术治疗)
Ana-Maria Gheorghe1,2, Claudiu Nistor3,4, Aurelian-Emil Ranetti5,6
1PhD Doctoral School, "Carol Davila" University of Medicine and Pharmacy, 0505474 Bucharest, Romania.
常态血性原发性甲状腺功能增强症 (NPHPT) 显著影响骨健康,骨质疏松症和骨折的发病率高. 副甲状腺切除术可以改善NPHPT患者的骨代谢.
科学领域:
- 内分泌学 在内分泌学.
- 代谢性骨疾病 代谢性骨疾病
背景情况:
- 常态血性原发性甲状腺功能障碍症 (NPHPT) 是原发性甲状腺功能障碍症 (PHPT) 的一种变体,患病率可变.
- 无症状的PHPT构成了当代医疗实践中大多数PHPT病例.
研究的目的:
- 在保守或手术管理下分析NPHPT患者的骨状况和矿物代谢.
- 为了比较NPHPT与高血性PHPT (HPHPT) 关于骨健康结果.
主要方法:
- 从2020年1月到2024年7月,PubMed搜索的研究进行了叙述性审查.
- 分析包括14项研究,包括388名NPHPT患者,1188名PHPT患者和803名对照.
主要成果:
- 骨质疏松症在41.7-100%的NPHPT受试者中流行.
- 在NPHPT中,骨折的患病率从7.4%到42.8%不等.
- 与PHPT相比,NPHPT的骨循环标记在NPHPT中较低,副甲状腺切除术后可能有改善.
结论:
- 由于潜在的并发症,早期诊断和治疗PHPT,包括NPHPT至关重要.
- 在患有骨质疏松症或结石的患者中增加查可能会识别NPHPT.
- 需要进一步的前性研究来澄清NPHPT的自然过程,并优化管理策略,包括副甲状腺切除术的指示.
更多相关视频
07:13Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
07:12Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
Published on: August 17, 2022
相关概念视频
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Skeleton and Calcium Homeostasis
Bone Remodeling
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
